SEROPREVALENCE OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS AMONG CHRONIC LIVER DISEASE PATIENTS IN A TERTIARY CARE HOSPITAL
European Journal of Molecular & Clinical Medicine,
2021, Volume 8, Issue 4, Pages 249-256
AbstractBackground: Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections account for a
substantial proportion of liver diseases worldwide. These viruses are responsible for liver
damages ranging from minor disorders to liver cirrhosis and hepatocellular carcinoma
(HCC). Approximately 7% of the world’s population (350 million people) are infected with
HBV and 3% (170million people) with HCV.
Aim & Objectives: To study Prevalence of Hepatitis B & Hepatitis C viruses infections in
Chronic liver disease patients .
Materials & Methods: A total of 100 Cases of CLD attending Gastroenterology department
were included in the study during the period of January 2015 – June 2016. Demographic
data and clinical findings were recorded using a structured proforma. All the samples were
screened for HBsAg detection( ERBALISA SEN HBsAg)& anti HCV antibodies detection by
ELISA (HCV MICROLISA) following the kit manufacturer’s instructions.
- Article View: 156
- PDF Download: 245